Literature DB >> 11126390

Cytokine and growth factor involvement in schizophrenia--support for the developmental model.

H Nawa1, M Takahashi, P H Patterson.   

Abstract

Medical treatment with various cytokines can provoke psychiatric symptoms. Conversely, psychiatric patients can display abnormalities in cytokine and neurotrophic factor expression. Such observations have pointed to the potential contribution of cytokines and growth factors to schizophrenic pathology and/or etiology. The cellular targets of the relevant factors and the nature of their actions remain to be explored in mental illness, however. Recent physiological studies demonstrate that cytokines and neurotrophic factors can markedly influence synaptic transmission and plasticity upon acute or chronic application. Moreover, many of the molecular alterations observed in the schizophrenic brain are consistent with abnormalities in cytokine and neurotrophic factor regulation of these molecules. In this review, we summarize these molecular pathology findings for schizophrenia and highlight the neurodevelopmental activities of cytokines and neurotrophic factors that may contribute to the etiology or pathology of this illness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11126390     DOI: 10.1038/sj.mp.4000730

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  32 in total

1.  Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice.

Authors:  D Ehninger; Y Sano; P J de Vries; K Dies; D Franz; D H Geschwind; M Kaur; Y-S Lee; W Li; J K Lowe; J A Nakagawa; M Sahin; K Smith; V Whittemore; A J Silva
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 2.  Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

Authors:  Anna M Fineberg; Lauren M Ellman
Journal:  Biol Psychiatry       Date:  2013-02-12       Impact factor: 13.382

3.  A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue.

Authors:  Edwin J C G van den Oord; Shaunna L Clark; Lin Ying Xie; Andrey A Shabalin; Mikhail G Dozmorov; Gaurav Kumar; Vladimir I Vladimirov; Patrik K E Magnusson; Karolina A Aberg
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

Review 4.  Maternal infection and white matter toxicity.

Authors:  G Jean Harry; Cindy Lawler; Susan H Brunssen
Journal:  Neurotoxicology       Date:  2006-05-17       Impact factor: 4.294

5.  MHCI negatively regulates synapse density during the establishment of cortical connections.

Authors:  Marian W Glynn; Bradford M Elmer; Paula A Garay; Xiao-Bo Liu; Leigh A Needleman; Faten El-Sabeawy; A Kimberley McAllister
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

Review 6.  Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research.

Authors:  Akiko Hayashi-Takagi; Marquis P Vawter; Kazuya Iwamoto
Journal:  Biol Psychiatry       Date:  2013-10-18       Impact factor: 13.382

7.  Association between Interleukin 31 Receptor A Gene Polymorphism and Schizophrenia in Korean Population.

Authors:  Ju Yeon Ban; Su Kang Kim; Hak-Jae Kim; Joo-Ho Chung; Tae Kim; Jin Kyung Park; Hyun-Kyung Park; Jong Woo Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

8.  Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development.

Authors:  Paula A Garay; Elaine Y Hsiao; Paul H Patterson; A K McAllister
Journal:  Brain Behav Immun       Date:  2012-07-25       Impact factor: 7.217

9.  Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population.

Authors:  Yuichiro Watanabe; Ayako Nunokawa; Masako Shibuya; Naoshi Kaneko; Hiroyuki Nawa; Toshiyuki Someya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

10.  Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation.

Authors:  Lee Zuckerman; Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-05-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.